ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.4352
+0.0129 (3.05%)
At close: May 12, 2025, 4:00 PM
0.4550
+0.0198 (4.55%)
After-hours: May 12, 2025, 7:59 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $23.26 million as of May 12, 2025. Its market cap has decreased by -97.16% in one year.
Market Cap
23.26M
Enterprise Value
-57.99M
1-Year Change
-97.16%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $23.26M, a decrease of -97.80%. That is a compound annual growth rate of -54.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 22.57M | -74.38% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |